Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fuji
UBS
Cipla
Queensland Health
Chinese Patent Office

Generated: April 20, 2019

DrugPatentWatch Database Preview

Details for Patent: 9,328,133

« Back to Dashboard

Which drugs does patent 9,328,133 protect, and when does it expire?

Patent 9,328,133 protects AURYXIA and is included in one NDA.

This patent has eighty-two patent family members in twenty countries.

Summary for Patent: 9,328,133
Title:Ferric organic compounds, uses thereof and methods of making same
Abstract: The present invention discloses a novel form of ferric organic compounds, including a form of ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. The ferric organic compounds of the present invention can be delivered effectively by oral route with better delivery to treat patients suffering from hyperphosphatemia, metabolic acidosis and other disorders responsive to ferric organic compound therapy.
Inventor(s): Kwok; David W. K. (Vancouver, CA), Stoynov; Nikolay Mintchev (Vancouver, CA)
Assignee: Panion & BF Biotech Inc. (TW)
Application Number:14/502,774
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 9,328,133
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 9,328,133
Patent Claim Types:
see list of patent claims
Formulation; Compound; Dosage form; Use; Composition;

Drugs Protected by US Patent 9,328,133

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Keryx Biopharms AURYXIA ferric citrate TABLET;ORAL 205874-001 Sep 5, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up Y Y CONTROL OF SERUM PHOSPHOROUS LEVELS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

International Family Members for US Patent 9,328,133

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2004213819 ➤ Sign Up
Australia 2006279333 ➤ Sign Up
Australia 2007210090 ➤ Sign Up
Australia 2007210096 ➤ Sign Up
Canada 2516471 ➤ Sign Up
Canada 2619591 ➤ Sign Up
Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Mallinckrodt
Cipla
Queensland Health
US Army
Chinese Patent Office
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.